Phase I/II study of paclitaxel and vinorelbine in metastatic breast cancer

Breast Cancer Research and Treatment

Volumn 47, Issue 1, 1998, Pages 91-97

  Tortoriello, Anna ^a   Facchini, Gaetano ^a   Caponigro, Francesco ^b   Santangelo, Michele ^c   Benassai, Giacomo ^c   Persico, Giovanni ^c   Citarella, Antonio ^d   Carola, Maria ^d   Marzano, Nicola ^e   Iaffaioli, Rosario Vincenzo ^a,c  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d Casa di Cura Villa Fiorita   (Italy)

^e Poliambulatorio di Oncologia   (Italy)

Author keywords

Metastatic breast cancer; Paclitaxel; Phase I II study; Vinorelbine

Indexed keywords

DEXAMETHASONE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; NAVELBINE; PACLITAXEL; PROMETHAZINE; RANITIDINE;

ANOREXIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST METASTASIS; CLINICAL TRIAL; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MICROTUBULE; NAUSEA; NEUTROPENIA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTOPENIA; VOMITING;

ADULT; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; PACLITAXEL; VINBLASTINE;

EID: 6844237666     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005848921895     Document Type: Article

References (17)

1. Henderson IC, Harris JR, Kinne DW, Hellman S: Cancer of breast. Treatment of metastases. In: De Vita VT Jr, Hellman S, Rosenberg SA (eds) Cancer Principles and Practice of Oncology. Lippincott, Philadelphia, 1989, pp 1245-1258
2. Potier P: The synthesis of Navelbine prototype of a new series of vinblastine derivatives. Semin Oncol 16 (suppl 4): 2-4, 1989
3. Binet S, Fellous A, Lataste H, Krikorian A. Couzinier JP, Meininger V: In situ analysis of the action of Navelbine on various types of microtubules using immunofluorescence. Semin Oncol 16 (suppl 4): 5-8, 1989
4. Fumoleau P, Delgado FM, Delozier T, Monnier A, Gil Delgado MA, Kerbrat P, Garcia-Giralt E, Keiling R, Namer M, Closon E, Goudier MJ, Chollet P, Lecourt L, Montcuquet P: Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy. J Clin Oncol 11: 1245-1252, 1993
5. Romero A, Rabinovich MG, Vallejo CT, Perez JE, Rodriguez R, Cuevas MA, Machiavelli M, Lacava JA, Longhi M, Romero Acuna L, Amato S, Barbieri R, Sabatini C, Leone BA: Vinorelbine as first-line chemotherapy for metastatic breast carcinoma. J Clin Oncol 12: 336-341, 1994
6. Canobbio L, Boccardo F, Pastorino G, Brema F, Martini C, Resasco M, Santi L: Phase II study of Navelbine in advanced breast cancer. Semin Oncol 16 (suppl 4): 33-36, 1989
7. Holmes FA, Walters RS, Theriault RL: Phase II trial of paclitaxel. and active drug in the treatment of metastatic breast cancer. J Natl Cancer Inst 83: 1797-1805, 1991
8. Reichman BS, Seidman AD, Crown JPA, Maclan R, Hakes TB, Lebwohl DE, Gilewski TA, Surbone A, Currie V, Hudis CA, Yao TJ, Klecker R, Jamis-Dow C, Collins J, Ouinlivan S, Berkery R, Toomasi F, Canetta R, Fisherman J, Arbuck S, Norton L: Paclitaxel and recombinant human granulocyte colony- stimulating factor as initial chemotherapy for metastatic breast cancer. J Clin Oncol 11: 1943-1951, 1993
9. Seidman AD, Reichman BS, Crown JPA, Yao TJ, Currie V, Hakes TB, Hudis CA, Gilewski TA, Boselga J, Forsythe P, Lepore J, Marks L, Fain K, Souhrada M, Onetto N, Arbuck S, Norton L: Paclitaxel as second and subsequent therapy for metastatic breast cancer: Activity independent of prior anthracycline response. J Clin Oncol 13: 1152-1159, 1995
10. Nabholtz JM, Gelman K, Bontenbal M, Spielmann M, Catimel G, Conte P, Klassen U, Namer M, Bonneterre J, Fumoleau P, Winograd B: Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer. J Clin Oncol 14: 1858-1867, 1996
11. Adams DJ: Synergy of Navelbine-Taxol combination treatment in two human breast cancer cell lines (Abstract). Proc Am Assoc Cancer Res 35: 1944, 1994
12. Knick VC, Eberwein DJ, Miller CG: Vinorelbine tartrate and paclitaxel combinations: enhanced activity against in vivo P388 murine leukemia cells. J Natl Cancer Inst 87: 1072-1077, 1995
13. Weber BL, Vogel C, Jones S, Harvey H, Hutchins L, Bigley J, Hohneker J: Intravenous vinorelbine as first-line and second-line therapy in advanced breast cancer. J Clin Oncol 13: 2722-2730, 1995
14. Eisenhauer E, Ten Bokkel Huinink W, Swenerton KD, Gianni L, Van der Burg MEL, Kerr I, Vermorken JB, Buser K, Colombo N, Bacon M, Santabarbara P, Onetto N, Winograd B, Canetta R: European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: High-dose versus low-dose and long versus short infusions. J Clin Oncol 12: 2654-2666, 1994
15. Chang AY, Garrow GC: Pilot study of vinorelbine (Navel-bine) and paclitaxel (Taxol) in patients with refractory breast cancer and lung cancer. Semin Oncol 22 (Suppl 5): 66-71, 1995
16. Ibrahim N, Hortobagyi GN, Valero V, Dhingra K, Willey J, Hohneker J, Buzdar AU: Phase I study of vinorelbine and paclitaxel by simultaneous 3-hour infusion for untreated metastatic breast cancer. Proc Am Assoc Cancer Res 36: 1443, 1995
17. Broxmeyer HE, Benninger L, Patel SR, Benjamin RS, Vadhan-Raj S: Kinetic response of human marrow myeloid progenitor cells to in vivo treatment in patients with granulocyte colony-stimulating factor is different from the response to treatment with granulocyte-macrophage colony-stimulating factor. Exp Hematol 22: 100-102, 1994